3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
3
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
29
Paclitaxel
7
Magnetic Resonance Spectroscopy
7
Cisplatin
7
Pemetrexed
6
Docetaxel
6
Carboplatin
6
Standard of Care
5
Radiotherapy
5
Nivolumab
5
Drug Therapy
5
Specimen Handling
4
Gemcitabine
4
Cetuximab
4
Blood Specimen Collection
4
epacadostat
3
X-Rays
3
Surveys and Questionnaires
3
Practice Guidelines as Topic
3
Oncolytic Virotherapy
3
Nicotine
3
Fluorouracil
3
Filgrastim
3
Cyclophosphamide
3
Bupropion
3
Bortezomib
3
Biopsy
3
spartalizumab
2
selpercatinib
2
sargramostim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Radionuclide Imaging
×
Head & Neck
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled